Home / Resource Library / IBCL-523 Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
IBCL-523 Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis